Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial
Published Online: 2013-09-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: A Murray Brunt•Andrew M Wardley•Anne Robinson•Anthony Howell•David Cameron•David Dodwell•Duncan Wheatley•Elizabeth Folkerd•Gill Coombes•Hui-Jung Sin•Jeremy P Braybrooke•Judith M Bliss•Kwok-Leung Cheung•Larry Hayward•Lucy S Kilburn•Mitch Dowsett•Nicole Sergenson•Paul Ellis•Rema Jyothirmayi•Stephen RD Johnston•Young-Hyuck Im
